INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,551,938 | -13.6% | 112,332 | +11.4% | 0.69% | +0.9% |
| Q2 2023 | $4,111,929 | +4348.7% | 100,832 | +3965.8% | 0.69% | +3711.1% |
| Q1 2023 | $92,430 | -96.3% | 2,480 | -96.5% | 0.02% | -96.3% |
| Q4 2022 | $2,490,448 | -37.6% | 71,380 | 0.0% | 0.48% | -38.8% |
| Q3 2022 | $3,994,000 | +8.1% | 71,380 | 0.0% | 0.79% | +5.6% |
| Q2 2022 | $3,695,000 | -29.6% | 71,380 | -1.1% | 0.74% | -20.0% |
| Q1 2022 | $5,247,000 | -38.0% | 72,200 | +0.8% | 0.93% | -26.9% |
| Q4 2021 | $8,466,000 | +0.3% | 71,600 | +13.8% | 1.27% | +81.5% |
| Q3 2021 | $8,438,000 | +263.7% | 62,900 | -48.9% | 0.70% | +207.9% |
| Q3 2016 | $2,320,000 | +58.3% | 123,159 | 0.0% | 0.23% | +51.0% |
| Q2 2016 | $1,466,000 | – | 123,159 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
| MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
| Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
| Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
| Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
| ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
| Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
| Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |